Sfoglia per Rivista JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Digital Dermoscopy Analysis in Telemedicine.
2006-01-01 Rubegni, Pietro; M., Burroni; Fimiani, Michele
Erfolgreiche Behandlung des therapierefraktären Sweet-Syndroms mit Adalimumab
2021-01-01 Calabrese, Laura; Caldarola, Giacomo; Peris, Ketty; De Simone, Clara
Extracorporeal photopheresis in graft-versus-host disease
2008-01-01 Carcagnì, M. R.; DE ALOE, G.; D'Ascenzo, G.; Rubegni, P.; Fimiani, M.
Folliculotropism in head and neck lentigo maligna and lentigo maligna melanoma
2021-01-01 Dika, E.; Lambertini, M.; Patrizi, A.; Misciali, C.; Scarfi, F.; Pellacani, G.; Mandel, V. D.; Di Tullio, F.; Stanganelli, I.; Chester, J.; Kaleci, S.; Massi, D.; De Giorgi, V.; Cinotti, E.; Rubegni, P.; Perrot, J. L.; Farnetani, F.
Follikulotropismus bei Lentigo maligna und Lentigo‐maligna‐Melanom im Kopf‐Hals‐Bereich
2021-01-01 Dika, Emi; Lambertini, Martina; Patrizi, Annalisa; Misciali, Cosimo; Scarfì, Federica; Pellacani, Giovanni; Mandel, Victor Desmond; Tullio, Francesca Di; Stanganelli, Ignazio; Chester, Johanna; Kaleci, Shaniko; Massi, Daniela; De Giorgi, Vincenzo; Cinotti, Elisa; Rubegni, Pietro; Perrot, Jean Luc; Farnetani, Francesca
P10 lpillimumab in a dose of 10mg/kg improves in patients sith melanoma in stage M1c the disease progression independent of lactat-dehydrogenase (LDH) level
2009-01-01 Smylie, M; Kaehler, Kc; Francis, S; Nyens, B; Maio, M; Minor, D; Verschraegen, C; Chin, K; Ibrahim, R; Hoos, A; Schadendorf, D
P7 Treatment with lpllimumab brings an advantage with reference to long-term survival: reflection rate after 24-months of patients with advanced melanoma from 3 phase II studies with 10mg/kg lpillimumab
2009-01-01 O'Day, Sj; Schadendorf, D; Weber, J; Lebbe, C; Maio, M; Pehamberger, H; Harmankaya, K; Siegel, J; Hoos, A; Humphrey, R; Wolchok, J
Recalcitrant Sweet Syndrome successfully treated with adalimumab
2021-01-01 Calabrese, L.; Caldarola, G.; Peris, K.; De Simone, C.
Specific cellular immune responses against NY-ESO-1 are associated with favorable survival of stage IV melanoma patients
2011-01-01 Weide, B; Zelba, H; Derhovanessian, E; Pflugfelder, A; Schadendorf, D; de Vries, J; Maio, M; Garbe, C; Pawelec, G
Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study
2025-01-01 Manzo Margiotta, F.; Dini, V.; Calabrese, L.; Lazzeri, L.; Conte, S. L.; Magliulo, M.; Montesi, G.; Pescitelli, L.; Milanesi, N.; Mazzatenta, C.; Antiga, E.; Rubegni, P.; Gola, M.; Romanelli, M.; Cartocci, A.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Digital Dermoscopy Analysis in Telemedicine. | 1-gen-2006 | Rubegni, Pietro; M., Burroni; Fimiani, Michele | - | |
| Erfolgreiche Behandlung des therapierefraktären Sweet-Syndroms mit Adalimumab | 1-gen-2021 | Calabrese, Laura; Caldarola, Giacomo; Peris, Ketty; De Simone, Clara | - | |
| Extracorporeal photopheresis in graft-versus-host disease | 1-gen-2008 | Carcagnì, M. R.; DE ALOE, G.; D'Ascenzo, G.; Rubegni, P.; Fimiani, M. | - | |
| Folliculotropism in head and neck lentigo maligna and lentigo maligna melanoma | 1-gen-2021 | Dika, E.; Lambertini, M.; Patrizi, A.; Misciali, C.; Scarfi, F.; Pellacani, G.; Mandel, V. D.; Di Tullio, F.; Stanganelli, I.; Chester, J.; Kaleci, S.; Massi, D.; De Giorgi, V.; Cinotti, E.; Rubegni, P.; Perrot, J. L.; Farnetani, F. | - | |
| Follikulotropismus bei Lentigo maligna und Lentigo‐maligna‐Melanom im Kopf‐Hals‐Bereich | 1-gen-2021 | Dika, Emi; Lambertini, Martina; Patrizi, Annalisa; Misciali, Cosimo; Scarfì, Federica; Pellacani, Giovanni; Mandel, Victor Desmond; Tullio, Francesca Di; Stanganelli, Ignazio; Chester, Johanna; Kaleci, Shaniko; Massi, Daniela; De Giorgi, Vincenzo; Cinotti, Elisa; Rubegni, Pietro; Perrot, Jean Luc; Farnetani, Francesca | - | |
| P10 lpillimumab in a dose of 10mg/kg improves in patients sith melanoma in stage M1c the disease progression independent of lactat-dehydrogenase (LDH) level | 1-gen-2009 | Smylie, M; Kaehler, Kc; Francis, S; Nyens, B; Maio, M; Minor, D; Verschraegen, C; Chin, K; Ibrahim, R; Hoos, A; Schadendorf, D | - | |
| P7 Treatment with lpllimumab brings an advantage with reference to long-term survival: reflection rate after 24-months of patients with advanced melanoma from 3 phase II studies with 10mg/kg lpillimumab | 1-gen-2009 | O'Day, Sj; Schadendorf, D; Weber, J; Lebbe, C; Maio, M; Pehamberger, H; Harmankaya, K; Siegel, J; Hoos, A; Humphrey, R; Wolchok, J | - | |
| Recalcitrant Sweet Syndrome successfully treated with adalimumab | 1-gen-2021 | Calabrese, L.; Caldarola, G.; Peris, K.; De Simone, C. | - | |
| Specific cellular immune responses against NY-ESO-1 are associated with favorable survival of stage IV melanoma patients | 1-gen-2011 | Weide, B; Zelba, H; Derhovanessian, E; Pflugfelder, A; Schadendorf, D; de Vries, J; Maio, M; Garbe, C; Pawelec, G | - | |
| Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study | 1-gen-2025 | Manzo Margiotta, F.; Dini, V.; Calabrese, L.; Lazzeri, L.; Conte, S. L.; Magliulo, M.; Montesi, G.; Pescitelli, L.; Milanesi, N.; Mazzatenta, C.; Antiga, E.; Rubegni, P.; Gola, M.; Romanelli, M.; Cartocci, A. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile